Sanofi/ US80105N1054 /
| 04/06/2024 19:06:59 | Chg. +0.0357 | Volume | Bid19:07:50 | Ask19:07:50 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 49.2857USD | +0.07% | 601,402 Turnover: 23.51 mill. |
49.2500Bid Size: 400 | 49.2900Ask Size: 200 | 122.95 bill.USD | - | - |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 4.31 EUR | -35.58% |
| EPS Diluted: | - EUR | - |
| Revenues per Share: | - EUR | - |
| Book Value per Share: | - EUR | - |
| Cash Flow per Share: | - EUR | - |
| Dividend per Share: | - EUR | - |
| Total | in mill. | |
| Revenues: | 43,070.00 EUR | 0.17% |
| Net Income: | 5,400.00 EUR | -35.49% |
| Operating Cash Flow: | 10,258.00 EUR | - |
| Cash and Cash Equivalents: | 8,710.00 EUR | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 10.51 | - |
| P/S Ratio: | - | - |
| P/BV ratio: | - | - |
| P/CF Ratio: | - | - |
| PEG: | -0.30 | - |
| Earnings Yield: | 9.51% | - |
| Dividend Yield: | 3.68% | - |
| Market Capitalization | ||
| Market Capitalization: | 122.95 bill. USD | 124.34 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 1.25 bill. | |
Profitability
| Gross Profit Margin: | 74.83% |
| EBIT Margin: | 18.28% |
| Net Profit Margin: | 12.54% |
| Return on Equity: | 7.29% |
| Return on Assets: | 4.28% |
Financial Strength
| Liquidity I / Cash Ratio: | 36.28% |
| Liquidity II / Quick Ratio: | 126.06% |
| Liquidity III / Current Ratio: | 127.69% |
| Debt / Equity Ratio: | 70.60% |
| Dynam. Debt / Equity Ratio: | 509.59% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - EUR |
| Revenues / Employee: | - EUR |
| Net Income / Employee: | - EUR |
| Total Assets / Employee: | - EUR |
| * Fiscal Year End: | 31/12/2023 |
| Accounting Standard: | IFRS |
| Currency: | EUR |
